DRW8D logo

Drägerwerk KGaA BATS-CHIXE:DRW8D Stock Report

Last Price

€43.80

Market Cap

€887.0m

7D

0%

1Y

n/a

Updated

23 Apr, 2024

Data

Company Financials +

Drägerwerk AG & Co. KGaA

BATS-CHIXE:DRW8D Stock Report

Market Cap: €887.0m

DRW8D Stock Overview

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide.

DRW8D fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Drägerwerk AG & Co. KGaA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Drägerwerk KGaA
Historical stock prices
Current Share Price€43.80
52 Week High€43.80
52 Week Low€41.70
Beta-0.18
1 Month Change3.67%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change4.29%
Change since IPO-40.63%

Recent News & Updates

Recent updates

Shareholder Returns

DRW8DGB Medical EquipmentGB Market
7D0%2.0%2.7%
1Yn/a-8.5%0.3%

Return vs Industry: Insufficient data to determine how DRW8D performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how DRW8D performed against the UK Market.

Price Volatility

Is DRW8D's price volatile compared to industry and market?
DRW8D volatility
DRW8D Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.1%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.7%

Stable Share Price: DRW8D has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine DRW8D's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
188915,750Stefan Dragerwww.draeger.com

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection.

Drägerwerk AG & Co. KGaA Fundamentals Summary

How do Drägerwerk KGaA's earnings and revenue compare to its market cap?
DRW8D fundamental statistics
Market cap€886.97m
Earnings (TTM)€110.43m
Revenue (TTM)€3.37b

8.6x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DRW8D income statement (TTM)
Revenue€3.37b
Cost of Revenue€1.91b
Gross Profit€1.46b
Other Expenses€1.35b
Earnings€110.43m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)5.89
Gross Margin43.27%
Net Profit Margin3.27%
Debt/Equity Ratio24.9%

How did DRW8D perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

31%

Payout Ratio

Does DRW8D pay a reliable dividends?

See DRW8D dividend history and benchmarks
When do you need to buy DRW8D by to receive an upcoming dividend?
Drägerwerk KGaA dividend dates
Ex Dividend DateMay 09 2024
Dividend Pay DateMay 13 2024
Days until Ex dividend15 days
Days until Dividend pay date19 days

Does DRW8D pay a reliable dividends?

See DRW8D dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.